| Literature DB >> 29143104 |
Yoshihisa Nakano1, Naoki Okumura2, Shiro Adachi2, Shigetake Shimokata1, Fumitaka Tajima1, Yoshihiro Kamimura1, Toyoaki Murohara1, Takahisa Kondo3.
Abstract
Little is known regarding a correlation of hemodynamics at rest or exercise capacity with echocardiographic parameters in patients with pulmonary hypertension (PH). To clarify these potential correlations, we performed transthoracic echocardiography, right heart catheterization, and cardiopulmonary exercise testing in 53 patients with pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH). Left ventricular end-diastolic dimension (LVDd), early diastolic velocity of the septal mitral annulus (septal e'), tricuspid regurgitation peak gradient (TRPG), and tricuspid annular plane systolic excursion (TAPSE) were significantly correlated with cardiac index (LVDd; r = 0.477, P < 0.001, septal e'; r = 0.463, P = 0.001, TRPG; r = - 0.455, P = 0.001 and TAPSE; r = 0.406, P = 0.003, respectively). Multiple regression analysis revealed that LVDd and septal e' were significantly associated with cardiac index (CI) and stroke volume index at rest. Among the exercise capacity markers evaluated, TAPSE, TRPG, and LVDd were significantly correlated with peak oxygen uptake (TAPSE; r = 0.534, P < 0.001, TRPG; r = - 0.466, P = 0.001 and LVDd; r = 0.411, P = 0.002, respectively). Multiple regression analysis showed that TAPSE was significantly associated with peak oxygen uptake (VO2). In PAH and CTEPH patients, LVDd and septal e' were significantly associated with CI at rest, whereas TAPSE was significantly associated with peak VO2. Echocardiographic parameters may predict the prognostic factors of PAH and CTEPH patients.Entities:
Keywords: Cardiac index; Echocardiography; Peak oxygen uptake; Pulmonary hypertension
Mesh:
Year: 2017 PMID: 29143104 PMCID: PMC5911277 DOI: 10.1007/s00380-017-1086-0
Source DB: PubMed Journal: Heart Vessels ISSN: 0910-8327 Impact factor: 2.037
Fig. 1Flowchart of the inclusion process. PH pulmonary hypertension; PAH pulmonary arterial hypertension; CTEPH chronic thromboembolic pulmonary hypertension; CHD congenital heart disease; PH-lung pulmonary hypertension associated with lung disease; PH-LHD pulmonary hypertension associated with left heart disease
Patient characteristics
| Number of patients | 53 |
| I/HPAH | 12 |
| POPH | 8 |
| CTD-PAH | 3 |
| CTEPH | 30 |
| Age (years) | 53.7 ± 15.2 |
| Male | 16 |
| Height (cm) | 159.3 ± 10.0 |
| Weight (kg) | 61.1 ± 16.0 |
| Body mass index (kg m−2) | 24.0 ± 5.9 |
| Body surface area (m2) | 1.6 ± 0.2 |
| WHO functional class | |
| 1/2/3/4 | 0/34/15/4 |
| 6MWD (m) | 380 ± 98 |
| Monotherapy | |
| ERA | 4 |
| PDE-5 | 4 |
| Combination therapy | |
| ERA + PDE-5 | 4 |
| Plasma BNP (pg/mL) | 102.0 (36.3–276.3) |
Data presented as mean ± SD, median (interquartile range) or n
I/HPAH idiopathic/heritable pulmonary arterial hypertension; POPH portopulmonary hypertension; CTD-PAH connective tissue disease-associated pulmonary arterial hypertension; CTEPH chronic thromboembolic pulmonary hypertension; WHO World Health Organization; 6MWD six-minute walk distance; ERA endothelin receptor antagonist; PDE-5 phosphodiesterase-5 inhibitor; BNP brain natriuretic peptide
Baseline measured variables
| Number of patients | 53 |
| Hemodynamics | |
| PAWP (mmHg) | 9.5 ± 3.7 |
| Mean ABP (mmHg) | 93.1 ± 13.6 |
| Mean RAP (mmHg) | 6.7 ± 4.3 |
| Systolic PAP (mmHg) | 80.0 ± 16.5 |
| Diastolic PAP (mmHg) | 28.9 ± 8.9 |
| Mean PAP (mmHg) | 47.8 ± 10.4 |
| Heart rate (bpm) | 76.5 ± 15.1 |
| SvO2 (%) | 63.5 ± 9.7 |
| SaO2 (%) | 91.9 ± 4.9 |
| CI (l/min/m2) | 2.1 ± 0.7 |
| SVI (l/m2) | 28.7 ± 10.5 |
| PVR (Wood Unit) | 12.6 ± 6.8 |
| Cardiopulmonary exercise test | |
| Peak VO2 (ml/kg/min) | 13.8 ± 4.1 |
| O2 pulse | 6.5 ± 2.2 |
| VE/VCO2 slope | 52.9 ± 17.7 |
| Peak RER | 1.0 ± 0.1 |
| Echocardiography | |
| LVDd (mm) | 40.1 ± 6.0 |
| LVDs (mm) | 25.3 ± 4.5 |
| IVSd (mm) | 8.3 ± 1.3 |
| LVPWd (mm) | 8.4 ± 1.3 |
| LAD (mm) | 32.4 ± 5.9 |
| TRPG (mmHg) | 74.1 ± 23.4 |
| TR grade | |
| I/II/III/IV | 9/17/15/11 |
| TAPSE (mm) | 17.3 ± 4.9 |
| E velocity (cm/s) | 56.8 ± 19.0 |
| A velocity (cm/s) | 69.5 ± 18.0 |
| E/A | 0.9 ± 0.4 |
| DcT (ms) | 224.8 ± 81.4 |
| Septal e′ (cm/s) | 5.2 ± 2.0 |
| E/e′ | 12.2 ± 5.4 |
Data are presented as mean ± SD or n
PAWP pulmonary artery wedge pressure; ABP arterial blood pressure; RAP right atrial pressure; PAP pulmonary artery pressure; SvO mixed venous oxygen saturation; SaO arterial oxygen saturation; CI cardiac index; SVI stroke volume index; PVR pulmonary vascular resistance; HR heart rate; VO oxygen uptake; VE minute ventilation; VCO carbon dioxide production; RER respiratory exchange ratio; LVDd left ventricular end-diastolic dimension; LVSd left ventricular end-systolic dimension; IVSd interventricular septal distance; LVPWd left ventricular posterior wall distance; LAD left atrial dimension; TRPG pressure gradient of tricuspid regurgitation; TR tricuspid regurgitation; TAPSE tricuspid annular plane systolic excursion; DcT deceleration time; e′ early diastolic velocity of mitral annulus
Fig. 2a Relation of cardiac index (CI) to left ventricular end-diastolic dimension (LVDd), early diastolic velocity of the septal mitral annulus (septal e′), tricuspid annular plane systolic excursion (TAPSE), and pressure gradient of tricuspid regurgitation (TRPG). b Relation of stroke volume index (SVI) to LVDd, e′, TAPSE, and TRPG
Independent predictors of cardiac index
| Variable | Standard coefficient |
|
|---|---|---|
| LVDd | 0.430 | < 0.001 |
| Septal e′ | 0.441 | 0.001 |
Independent predictors of stroke volume index
| Variable | Standard coefficient |
|
|---|---|---|
| LVDd | 0.479 | < 0.001 |
| Septal e′ | 0.383 | < 0.001 |
| BNP | − 0.276 | 0.01 |
LVDd left ventricular end-diastolic dimension; e′ early diastolic velocity of the septal mitral annulus; HR heart rate; BNP brain natriuretic peptide
Fig. 3Relation of peak oxygen uptake (VO2) to left ventricular end-diastolic dimension (LVDd), early diastolic velocity of the septal mitral annulus (septal e′), tricuspid annular plane systolic excursion (TAPSE), and pressure gradient of tricuspid regurgitation (TRPG)
Independent predictors of peak oxygen uptake
| Variable | Standard coefficient |
|
|---|---|---|
| TAPSE | 0.544 | < 0.001 |
| SvO2 | 0.329 | 0.005 |
TAPSE tricuspid annular plane systolic excursion; SvO mixed venous oxygen saturation